# Extracorporeal membrane oxygenation (ECMO)

Intervention · id `cardio:extracorporeal-membrane-oxygenation-ecmo` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: ECMO; Extracorporeal membrane oxygenation; Extracorporeal life support

Browse, organ or system: Heart  
Browse, condition area: Acute care and long-term living  

## In plain language

ECMO is a form of life support. Blood is circulated outside the body through a system that adds oxygen, which may include a pump, a membrane oxygenator and a heat exchanger. MeSH names respiratory failure and cardiac failure among its uses. This page records one registered randomized trial, ECLS-SHOCK, which compares extracorporeal life support added to revascularisation and medical treatment with the same care alone in people with a heart attack and cardiogenic shock. The registry says extracorporeal life support, not ECMO. The registry entry lists 420 people and has no results, so this page states no outcome.

## Technical summary

MeSH descriptor D015199 (Extracorporeal Membrane Oxygenation), an exact match; the scope note is on concept M0023354. Evidence in this atlas: the ClinicalTrials.gov record NCT03637205 (ECLS-SHOCK), read as a registry entry only. The registry calls the intervention ECLS insertion; it does not use the word ECMO and does not say which extracorporeal system or configuration was used. MeSH lists "Extracorporeal Life Support" as an entry term of its ECMO concept, and this page files the trial here on that basis only. No study record or trial report is filed for ECLS-SHOCK. The temporary-support page covers venoarterial ECMO among other temporary pumps. The device itself, the circuit, has its own page.

## Claims, with the population each applies to

## Context: Adults aged 18 to 75 in the ECLS-SHOCK registry record: acute myocardial infarction with cardiogenic shock

Recipient: Adult; Population: People with acute myocardial infarction complicated by cardiogenic shock who undergo revascularisation, as the registry title and conditions describe them. The registry gives a minimum age of 18 years and a maximum of 75 years.; Care setting: Hospital care in Germany and Slovenia (registry location countries; hospital care is inferred from the intervention, not stated by the registry); Geography: Germany and Slovenia (registry location countries); Life stage: Adults, 18 to 75 years (registry eligibility ages); Follow-up: Primary outcome in the registry: 30-day mortality; the first secondary outcome is timed at 6 and 12 months

### ClinicalTrials.gov record NCT03637205 (ECLS-SHOCK, record last updated 13 December 2024, read on 8 November 2026) describes a randomized trial in people with acute myocardial infarction and cardiogenic shock aged 18 to 75. One arm adds extracorporeal life support to revascularisation and medical treatment, and the other has the same care without it. The record lists 30-day mortality as the primary outcome and 420 participants enrolled (actual count), with the overall status completed. The record has no results section.

- Category: Description
- Evidence stage: Evidence stage not applicable
- Certainty: Certainty not assessed
- Applies to: Recipient: Adult; Population: People with acute myocardial infarction complicated by cardiogenic shock who undergo revascularisation, as the registry title and conditions describe them. The registry gives a minimum age of 18 years and a maximum of 75 years.; Care setting: Hospital care in Germany and Slovenia (registry location countries; hospital care is inferred from the intervention, not stated by the registry); Geography: Germany and Slovenia (registry location countries); Life stage: Adults, 18 to 75 years (registry eligibility ages); Follow-up: Primary outcome in the registry: 30-day mortality; the first secondary outcome is timed at 6 and 12 months
- Limitations: This claim records a registry entry, not a trial result. The registry names the intervention extracorporeal life support (ECLS insertion); it does not use the word ECMO and does not say which extracorporeal system or configuration was used. The claim is filed on the ECMO page because MeSH lists "Extracorporeal Life Support" as an entry term of its ECMO concept; the registry itself does not state that link. No outcome, benefit or harm is recorded here. The record is dated by its last update, and the sponsor may change it.
- Last checked: 2026-11-08
- Sources:
  1. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.identificationModule.briefTitle. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  2. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.designModule.enrollmentInfo.count. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  3. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.designModule.enrollmentInfo.type. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  4. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.conditionsModule.conditions\[0\]. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  5. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.conditionsModule.conditions\[1\]. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  6. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.armsInterventionsModule.armGroups\[0\].description. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  7. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.armsInterventionsModule.interventions\[0\].name. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  8. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.outcomesModule.primaryOutcomes\[0\].measure. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  9. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.outcomesModule.primaryOutcomes\[0\].timeFrame. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  10. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.eligibilityModule.minimumAge. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  11. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.eligibilityModule.maximumAge. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  12. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.statusModule.overallStatus. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  13. Supports: Extracorporeal Life Support in Cardiogenic Shock (Registry, edition ClinicalTrials.gov API v2 record, last update posted 2024-12-13.) <https://clinicaltrials.gov/study/NCT03637205>
     Locator: protocolSection.armsInterventionsModule.armGroups\[1\].description. Retrieved 2026-11-08T20:42:20Z. Source state: Current. Version fingerprint: 35a720b1aa32fdc186c52b3dfd2c72317b73323a295d4bc706dff4ac4a7c46b4.
     How it applies: Quoted at this locator.
  14. Background: MeSH descriptor D015199 (Extracorporeal Membrane Oxygenation) (Dataset, edition MeSH linked-data descriptor record and its preferred concept record M0023354 (the scope note is on the concept record), fetched 2026-11-08, and the record of term T000900886 (Extracorporeal Life Support), one of the terms the concept record lists, fetched 2026-11-09. The record states no yearly MeSH release.) <https://id.nlm.nih.gov/mesh/D015199>
     Locator: term\[2\]. Retrieved 2026-11-08T20:40:24Z. Source state: Current. Version fingerprint: 94202b8d07d1288f9dbd410c654a0cf9b2cb3e9ec6b81702ff4d17345429bb01.
     How it applies: The MeSH ECMO concept lists term T000900886; quoted at this locator. Basis for filing the claim on the ECMO page, not evidence about the trial.
  15. Background: MeSH descriptor D015199 (Extracorporeal Membrane Oxygenation) (Dataset, edition MeSH linked-data descriptor record and its preferred concept record M0023354 (the scope note is on the concept record), fetched 2026-11-08, and the record of term T000900886 (Extracorporeal Life Support), one of the terms the concept record lists, fetched 2026-11-09. The record states no yearly MeSH release.) <https://id.nlm.nih.gov/mesh/D015199>
     Locator: prefLabel.@value. Retrieved 2026-11-09T03:27:40Z. Source state: Current. Version fingerprint: cb21ba7135a906d62dbcbf5867ff9fa7e184ab8284cf7fd865cbdc98bf5d62ff.
     How it applies: The MeSH term T000900886 reads Extracorporeal Life Support; quoted at this locator. Basis for filing the claim on the ECMO page, not evidence about the trial.

## Connected pages

- Registered randomized trial ECLS-SHOCK: extracorporeal life support added to usual care in heart attack with cardiogenic shock (registry entry; no result recorded): Cardiogenic shock (`cardio:cardiogenic-shock`) [a claim, not a settled fact; see claim `cardio:claim-ecls-shock-registry-record` and its context]
- The procedure uses an extracorporeal circuit: Extracorporeal membrane oxygenation circuit (`cardio:extracorporeal-membrane-oxygenation-circuit`)
- The temporary-support page lists venoarterial ECMO among temporary supports: Temporary mechanical circulatory support (heart pumps) (`cardio:mechanical-circulatory-support`)
- Filed under this front: Emergency and acute care (`cardio:front-emergency-and-acute-care`)

## Provenance

Content hash: b5c45ad5a715e7d764154faba13b9a44f1683a070b4b195d68d75c848adece52
Last substantive edit: 2026-11-08
Evidence last checked: 2026-11-08
